Amgen (AMGN) has had the highest return between October 4, 1985 and October 4, 2025 by a US stock in the Biotechnology Industry with a market cap of $10B+, returning 252,563.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Amgen (AMGN) | 10/4/1985 - 10/4/2025 | 252,563.27% |
Gilead Sciences (GILD) | 10/4/1985 - 10/4/2025 | 29,791.25% |
Vertex Pharmaceuticals (VRTX) | 10/4/1985 - 10/4/2025 | 8,862.22% |
Alnylam Pharmaceuticals (ALNY) | 10/4/1985 - 10/4/2025 | 7,381.15% |
United Therapeutics (UTHR) | 10/4/1985 - 10/4/2025 | 6,612.05% |
Biogen (BIIB) | 10/4/1985 - 10/4/2025 | 5,229.33% |
Incyte (INCY) | 10/4/1985 - 10/4/2025 | 4,532% |
argenx NV ADR (ARGX) | 10/4/1985 - 10/4/2025 | 4,369.27% |
Regeneron Pharmaceuticals (REGN) | 10/4/1985 - 10/4/2025 | 2,638.96% |
BeiGene (ONC) | 10/4/1985 - 10/4/2025 | 1,086.99% |
Neurocrine Biosciences (NBIX) | 10/4/1985 - 10/4/2025 | 996.24% |
AbbVie (ABBV) | 10/4/1985 - 10/4/2025 | 954.88% |
Ascendis Pharma A-S (ASND) | 10/4/1985 - 10/4/2025 | 849.07% |
Genmab A-S (GMAB) | 10/4/1985 - 10/4/2025 | 789.71% |
Natera (NTRA) | 10/4/1985 - 10/4/2025 | 657.24% |
Ionis Pharmaceuticals (IONS) | 10/4/1985 - 10/4/2025 | 597.61% |
BioNTech SE (BNTX) | 10/4/1985 - 10/4/2025 | 539.33% |
EXACT Sciences (EXAS) | 10/4/1985 - 10/4/2025 | 284.54% |
Biomarin Pharmaceutical (BMRN) | 10/4/1985 - 10/4/2025 | 269.53% |
Exelixis (EXEL) | 10/4/1985 - 10/4/2025 | 122.72% |
Summit Therapeutics (SMMT) | 10/4/1985 - 10/4/2025 | 116.46% |
BridgeBio Pharma (BBIO) | 10/4/1985 - 10/4/2025 | 72.69% |
Roivant Sciences (ROIV) | 10/4/1985 - 10/4/2025 | 54% |
Moderna (MRNA) | 10/4/1985 - 10/4/2025 | 29.5% |
Madrigal Pharmaceuticals (MDGL) | 10/4/1985 - 10/4/2025 | 26.57% |
